Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis

Background Intragastric balloons have been used since 1985 to treat obesity, but an evidence-based systematic review had not been previously performed. The objective of this study is to determine the safety, efficacy, and effectiveness of the most widely used balloon, BioEnterics Intragastric Balloo...

Full description

Saved in:
Bibliographic Details
Published in:Obesity surgery 2008-07, Vol.18 (7), p.841-846
Main Authors: Imaz, Iñaki, Martínez-Cervell, Carmen, García-Álvarez, Elvira Elena, Sendra-Gutiérrez, Juan Manuel, González-Enríquez, Jesús
Format: Article
Language:English
Subjects:
Device Removal
Effectiveness
Gastric Balloon - adverse effects
Humans
Medical procedures
Medicine
Medicine & Public Health
Meta-analysis
Obesity
Obesity - therapy
Patient safety
Research Article
Surgery
Treatment Outcome
Weight Loss
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Intragastric balloons have been used since 1985 to treat obesity, but an evidence-based systematic review had not been previously performed. The objective of this study is to determine the safety, efficacy, and effectiveness of the most widely used balloon, BioEnterics Intragastric Balloon (BIB®), to treat obesity. Methods Systematic literature review of Medline, Embase, and other information sources from inception to March 2006. The quality of selected studies was assessed. Meta-analysis of weighted mean difference was made using the inverse variance method. Results We pooled 15 articles (3,608 patients) to estimate BIBs® effectiveness. The estimates for weight lost at balloon removal for BIB® were the following: 14.7 kg, 12.2% of initial weight, 5.7 kg/m 2 , and 32.1% of excess weight. However, data were scant after balloon removal. Yet, efficacy at balloon removal was estimated with a meta-analysis of two randomized controlled trials (75 patients) that compared balloon versus placebo, indicating the balloon group lost more weight than the placebo group. These differences in weight lost were 6.7 kg, 1.5% of initial weight, 3.2 kg/m 2 , and 17.6% of excess weight. Regarding BIB® safety, the majority of complications were mild and the early removal rate was 4.2%. Conclusion The use of the BIB®, within a multidisciplinary weight management program, is a short-term effective treatment to lose weight, but it is not yet possible to verify its capacity to maintain the weight lost over a long period of time.
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-007-9331-8